These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

816 related items for PubMed ID: 19040476

  • 1. Incidence, risk factors and outcomes of Escherichia coli bloodstream infections in a large Canadian region.
    Laupland KB, Gregson DB, Church DL, Ross T, Pitout JD.
    Clin Microbiol Infect; 2008 Nov; 14(11):1041-7. PubMed ID: 19040476
    [Abstract] [Full Text] [Related]

  • 2. Incidence, risk factors, and outcomes of Klebsiella pneumoniae bacteremia.
    Meatherall BL, Gregson D, Ross T, Pitout JD, Laupland KB.
    Am J Med; 2009 Sep; 122(9):866-73. PubMed ID: 19699383
    [Abstract] [Full Text] [Related]

  • 3. Staphylococcus aureus bloodstream infections: risk factors, outcomes, and the influence of methicillin resistance in Calgary, Canada, 2000-2006.
    Laupland KB, Ross T, Gregson DB.
    J Infect Dis; 2008 Aug 01; 198(3):336-43. PubMed ID: 18522502
    [Abstract] [Full Text] [Related]

  • 4. Clinical significance of healthcare-associated infections in community-onset Escherichia coli bacteraemia.
    Cheong HS, Kang CI, Kwon KT, Heo ST, Wi YM, Kim ES, Lee JS, Ko KS, Chung DR, Lee NY, Song JH, Peck KR.
    J Antimicrob Chemother; 2007 Dec 01; 60(6):1355-60. PubMed ID: 17923453
    [Abstract] [Full Text] [Related]

  • 5. Community-onset extended-spectrum beta-lactamase (ESBL) producing Escherichia coli: importance of international travel.
    Laupland KB, Church DL, Vidakovich J, Mucenski M, Pitout JD.
    J Infect; 2008 Dec 01; 57(6):441-8. PubMed ID: 18990451
    [Abstract] [Full Text] [Related]

  • 6. Emergence of extended-spectrum β-lactamase-producing escherichia coli as a cause of community-onset bacteremia in South Korea: risk factors and clinical outcomes.
    Park SH, Choi SM, Lee DG, Kim J, Choi JH, Kim SH, Kwon JC, Yoo JH.
    Microb Drug Resist; 2011 Dec 01; 17(4):537-44. PubMed ID: 21875342
    [Abstract] [Full Text] [Related]

  • 7. Risk factors and treatment outcomes of community-onset bacteraemia caused by extended-spectrum beta-lactamase-producing Escherichia coli.
    Kang CI, Song JH, Chung DR, Peck KR, Ko KS, Yeom JS, Ki HK, Son JS, Lee SS, Kim YS, Jung SI, Kim SW, Chang HH, Ryu SY, Kwon KT, Lee H, Moon C, Shin SY, Korean Network for Study of Infectious Diseases (KONSID).
    Int J Antimicrob Agents; 2010 Sep 01; 36(3):284-7. PubMed ID: 20580534
    [Abstract] [Full Text] [Related]

  • 8. Epidemiology of Clostridium species bacteremia in Calgary, Canada, 2000-2006.
    Leal J, Gregson DB, Ross T, Church DL, Laupland KB.
    J Infect; 2008 Sep 01; 57(3):198-203. PubMed ID: 18672296
    [Abstract] [Full Text] [Related]

  • 9. Community-onset urinary tract infections: a population-based assessment.
    Laupland KB, Ross T, Pitout JD, Church DL, Gregson DB.
    Infection; 2007 Jun 01; 35(3):150-3. PubMed ID: 17565455
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Evaluation of risk factors for the acquisition of bloodstream infections with extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella species in the intensive care unit; antibiotic management and clinical outcome.
    Cordery RJ, Roberts CH, Cooper SJ, Bellinghan G, Shetty N.
    J Hosp Infect; 2008 Feb 01; 68(2):108-15. PubMed ID: 18063198
    [Abstract] [Full Text] [Related]

  • 12. Virulence factors and phylogenetic grouping of Escherichia coli isolates from patients with bacteraemia of urinary tract origin relate to sex and hospital- vs. community-acquired origin.
    Skjøt-Rasmussen L, Ejrnæs K, Lundgren B, Hammerum AM, Frimodt-Møller N.
    Int J Med Microbiol; 2012 Jul 01; 302(3):129-34. PubMed ID: 22571989
    [Abstract] [Full Text] [Related]

  • 13. The changing burden of pediatric bloodstream infections in Calgary, Canada, 2000-2006.
    Laupland KB, Gregson DB, Vanderkooi OG, Ross T, Kellner JD.
    Pediatr Infect Dis J; 2009 Feb 01; 28(2):114-7. PubMed ID: 19116605
    [Abstract] [Full Text] [Related]

  • 14. Escherichia coli phylogenetic groups are associated with site of infection and level of antibiotic resistance in community-acquired bacteraemia: a 10 year population-based study in Denmark.
    Bukh AS, Schønheyder HC, Emmersen JM, Søgaard M, Bastholm S, Roslev P.
    J Antimicrob Chemother; 2009 Jul 01; 64(1):163-8. PubMed ID: 19429665
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Clinical consequences of increased ciprofloxacin and gentamicin resistance in patients with Escherichia coli bacteraemia in the Netherlands.
    Cranendonk DR, van der Valk M, Langenberg ML, van der Meer JT.
    Scand J Infect Dis; 2012 May 01; 44(5):363-8. PubMed ID: 22200089
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Epidemiology of community-acquired and nosocomial bloodstream infections in tropical Australia: a 12-month prospective study.
    Douglas MW, Lum G, Roy J, Fisher DA, Anstey NM, Currie BJ.
    Trop Med Int Health; 2004 Jul 01; 9(7):795-804. PubMed ID: 15228489
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Descriptive epidemiology of Escherichia coli bacteraemia in England, April 2012 to March 2014.
    Bou-Antoun S, Davies J, Guy R, Johnson AP, Sheridan EA, Hope RJ.
    Euro Surveill; 2016 Sep 01; 21(35):. PubMed ID: 27608263
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 41.